NYSE:OMI - Owens & Minor Stock Price, News & Analysis

Owens & Minor trades on the New York Stock Exchange (NYSE) under the ticker symbol "OMI."

Owens & Minor declared a quarterly dividend on Wednesday, August 7th. Shareholders of record on Monday, September 16th will be given a dividend of $0.002 per share on Monday, September 30th. This represents a $0.01 annualized dividend and a yield of 0.14%. The ex-dividend date is Friday, September 13th. View Owens & Minor's Dividend History.

Owens & Minor, Inc. (NYSE:OMI) released its quarterly earnings results on Wednesday, August, 7th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.07 by $0.03. The business earned $2.48 billion during the quarter, compared to analyst estimates of $2.44 billion. Owens & Minor had a negative net margin of 2.88% and a positive return on equity of 5.53%. The business's quarterly revenue was up 1.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.32 earnings per share. View Owens & Minor's Earnings History.

Owens & Minor is scheduled to release their next quarterly earnings announcement on Wednesday, October 30th 2019. View Earnings Estimates for Owens & Minor.

Owens & Minor issued an update on its FY 2019 earnings guidance on Wednesday, August, 7th. The company provided earnings per share guidance of $0.60-0.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.61.

5 analysts have issued 1 year price objectives for Owens & Minor's shares. Their predictions range from $5.00 to $9.00. On average, they expect Owens & Minor's share price to reach $7.30 in the next year. This suggests a possible upside of 31.1% from the stock's current price. View Analyst Price Targets for Owens & Minor.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Owens & Minor in the last year. There are currently 1 sell rating and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Owens & Minor.

Media coverage about OMI stock has trended negative on Thursday, according to InfoTrie Sentiment. The research group scores the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Owens & Minor earned a news sentiment score of -2.9 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for Owens & Minor.

Some companies that are related to Owens & Minor include Ironwood Pharmaceuticals (IRWD), Polynovo (PNV), Atrion (ATRI), Brookdale Senior Living (BKD), Supernus Pharmaceuticals (SUPN), Regenxbio (RGNX), Hexo (HEXO), Audentes Therapeutics (BOLD), Aimmune Therapeutics (AIMT), Rhoen Klinikum (RHK), BioTelemetry (BEAT), Gossamer Bio (GOSS), Coherus Biosciences (CHRS), Opko Health (OPK) and Enanta Pharmaceuticals (ENTA).

Based on aggregate information from My MarketBeat watchlists, some companies that other Owens & Minor investors own include AT&T (T), Micron Technology (MU), AbbVie (ABBV), Alibaba Group (BABA), Omega Healthcare Investors (OHI), Applied Materials (AMAT), Cisco Systems (CSCO), Tanger Factory Outlet Centers (SKT), 3M (MMM) and Simon Property Group (SPG).

Owens & Minor's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.86%), Vanguard Group Inc. (7.55%), JPMorgan Chase & Co. (4.55%), Blackstone Group Inc (4.11%), Invesco Ltd. (3.82%) and Morgan Stanley (2.86%). Company insiders that own Owens & Minor stock include Charles C Colpo and Geoff Taylor Marlatt. View Institutional Ownership Trends for Owens & Minor.

OMI stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Parametric Portfolio Associates LLC, SG Americas Securities LLC, LSV Asset Management, Wells Fargo & Company MN, GSA Capital Partners LLP, Cubist Systematic Strategies LLC and Aperio Group LLC. View Insider Buying and Selling for Owens & Minor.

OMI stock was bought by a variety of institutional investors in the last quarter, including Blackstone Group Inc, Invesco Ltd., Renaissance Technologies LLC, Morgan Stanley, BlackRock Inc., Marshall Wace North America L.P., Bank of New York Mellon Corp and Commonwealth Bank of Australia. View Insider Buying and Selling for Owens & Minor.

Shares of OMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of OMI stock can currently be purchased for approximately $5.57.

Owens & Minor has a market capitalization of $350.69 million and generates $9.84 billion in revenue each year. The company earns $-437,010,000.00 in net income (profit) each year or $1.15 on an earnings per share basis. Owens & Minor employs 17,900 workers across the globe.View Additional Information About Owens & Minor.

The official website for Owens & Minor is http://www.owens-minor.com/.

Owens & Minor's mailing address is 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23261. The company can be reached via phone at 804-723-7000 or via email at [email protected]